The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Building an In-House Cell and Gene Therapy Manufacturing Facility during the Pandemic The impact and disruption caused by the COVID-19 pandemic added an unprecedented level of risk and complexity for companies like Expression Therapeutics who were in the midst of constructing a new manufacturing facility. By taking a flexible project execution approach including pre-fabricated cleanrooms, the company was able to adapt to the situation and overcome the challenges ultimately resulting in the successful completion of the project on time and under budget. The project case study will be presented.
Speaker(s):
Mr. Dennis
Powers,
Vice President of Business Development & Design Consulting,
G-CON Manufacturing